Recent Post
Aussies avoiding what matters most in last stage of life
Experts issuing public health plea for improved communication, acceptance and preparation for last stage of life Of the 160,000 Australian deaths recorded each year, more than 60 per cent (100,000) are predictable, and can therefore, be planned for. Yet concerningly, less than one in six Australians (15 per cent) have care plans in place for…
Read MoreEndometriosis Awareness Month – March into Yellow
This March, Endometriosis Australia are calling for everyone to ‘March into Yellow’ to raise awareness of endometriosis and encourage public discussion on the largely invisible illness. Endometriosis affects more than 830,000 women in Australia and occurs when tissue similar to the uterus lining forms outside of the womb, growing around the ovaries, bowel and pelvis…
Read MoreVIVA! talks to Professor Anna DeFazio about Ovarian Cancer
February is Ovarian Cancer Awareness month, dedicated to raising much needed awareness and funds for research to improve management of this deadly disease and providing support for women diagnosed and their families. This week, we spoke with Professor Anna DeFazio – the Sydney-West Chair in Translational Cancer Research, The University of Sydney and Director of…
Read MoreIt’s not goodbye, it’s see you later
Regulatory codes, compliance teams, acronyms and writing gut-wrenching patient case studies were probably the first and hardest things to get my head around when I jumped headfirst into the healthcare industry and life at VIVA! Communications almost four years ago. As a Brit coming Down Under from an in-house role in the sports industry, there…
Read MoreLaunch of GLOBALHealthPR’s ‘Global Guide to Market Access’
New resource enabling biopharma industry to navigate access & reimbursement landscape across 26 countries GLOBALHealthPRTM (GHPR) – the world’s largest independent health and science communications agency partnership – has today launched the Global Guide to Market Access – an invaluable industry resource providing local insights into the biopharmaceutical reimbursement landscape in 26 countries. VIVA! Communications…
Read More